Erste Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$39.7M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.6M |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$10.1M |
| 4 |
Westlake Corp
WLK
|
+$8.6M |
| 5 |
Booking.com
BKNG
|
+$6.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$26.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$20.8M |
| 3 |
TIF
Tiffany & Co.
TIF
|
+$8.44M |
| 4 |
iShares Semiconductor ETF
SOXX
|
+$7.14M |
| 5 |
Roper Technologies
ROP
|
+$5.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.5% |
| 2 | Technology | 20.83% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 9.34% |
| 5 | Communication Services | 6.05% |
Similar funds
Erste Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, Erste Asset Management held 443 positions worth $2.26B, up 20% from $1.88B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Erste Asset Management deployed $115M of net new capital in Q4 2019, opening 33 new positions and adding to 160 existing holdings. Its largest new stake was Westlake Corp: 128,000 shares worth $8.83M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $26.3M trimmed.
- Erste Asset Management's largest Q4 2019 buy was Westlake Corp: 128,000 shares worth $8.83M.
- Erste Asset Management added most to Biogen in Q4 2019, an estimated $39.7M increase.
- Erste Asset Management's biggest Q4 2019 reduction was Vertex Pharmaceuticals, cutting an estimated $26.3M.
- Erste Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $20.8M.
- Erste Asset Management's ten largest holdings make up 22% of its $2.26B portfolio in Q4 2019.
- Erste Asset Management opened 33 new positions and closed 38 in Q4 2019.
- Erste Asset Management's portfolio value rose 20% quarter-over-quarter to $2.26B.
Based on Erste Asset Management's 13F filing for Q4 2019, filed 22 Nov 2024.